MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer
Macrophages confer resistance to BET inhibition in triple-negative
Opnurasib (JDQ-443) is an Orally Active KRAS G12C Inhibitor
Rociletinib (CO-1686) is an Orally Active EGFR-Mutant Inhibitor
Triple-Negative Breast Cancer - Network of Cancer Research
SC-43 is a Potent and Orally Active SHP-1 Agonist and STAT3
Elesclomol (STA-4783) is an Oxidative Stress Inducer and Induces Apoptosis
RETRACTED ARTICLE: A new synthetic derivative of cryptotanshinone
Purinostat mesylate is a Selective HDAC Inhibitor With anti-Leukemia Effects
triple-negative breast cancer MedChemExpress (MCE) Life Science
MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer
Navitoclax (ABT-263) is an Orally Active Bcl-2 Inhibitor for
DC-5163, a GAPDH Inhibitor, Inhibits Glycolysis Pathway and Induces Apoptosis
triple-negative breast cancer MedChemExpress (MCE) Life Science
Arnicolide D Inhibits Triple Negative Breast Cancer Cell
Established synthetic method of psammaplin A analog and